Malignant Transformation of an Ovarian Endometrioma during Endometriosis Treatment: A Case Report
Dienogest (DNG) is considered to be effective against ovarian endometrioma (OMA). We report a rare case of OMA transformation to ovarian cancer during long-term endometriosis treatment with a periodic administration of a gonadotropin-releasing hormone agonist (Gn-RH agonist) and DNG. The patient was...
Saved in:
Main Authors: | Hiroaki Takagi (Author), Emi Takata (Author), Jinichi Sakamoto (Author), Satoko Fujita (Author), Masahiro Takakura (Author), Toshiyuki Sasagawa (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest
by: Hiroaki Takagi, et al.
Published: (2023) -
Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma
by: Joo-Hyuk Son, et al.
Published: (2019) -
Factors in malignant transformation of ovarian endometriosis: A narrative review
by: Andrea Giannini, et al.
Published: (2024) -
Ecto-nucleotidases Activities in the Contents of Ovarian Endometriomas: Potential Biomarkers of Endometriosis
by: Laura Texidó, et al.
Published: (2014) -
The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer
by: Natsuho Nakamura, et al.
Published: (2020)